NCT05163015

Brief Summary

Among patients with cancer, 6 in 10 are over 65 years of age. In order to improve quality of life of aged cancer patients, the oncogeriatric consultation has been created. Oncogeriatric consultation aim to help oncologists determine the best solutions to combine therapy and quality of life. Factors influencing quality of life of cancer patients have been studied previously. However, these studies always focus on one specific cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 20, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

January 4, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

March 25, 2022

Status Verified

January 1, 2022

Enrollment Period

5 months

First QC Date

December 6, 2021

Last Update Submit

March 9, 2022

Conditions

Keywords

Cancersaged patientsoncogeriatric consultationquality of life

Outcome Measures

Primary Outcomes (2)

  • EORTC QLQ-C30

    The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)). Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life). Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).

    Day 0

  • EORTC QLQ-C30

    The QLQ-C30 is a generic questionnaire with 30 questions coded in 4 response modalities (not at all (1), a little (2), enough (3), a lot (4)) or in 7 response modalities (from very bad (1) to excellent ( 7)). Questions are summarized in five multiitem domains (physical, role, cognitive, emotional, and social functioning) and nine single item domains (fatigue, pain, nausea/vomiting, appetite loss, financial impact; diarrhea, constipation, sleep disturbance and quality of life). Each domain is scored between 0 and 100. For functional domains, a high score value represents a high level of quality of life. For symptom domains, a high score represents an important level of symptoms (a low level of quality of life).

    Day 60

Study Arms (2)

with oncogeriatric consultation

with oncogeriatric consultation" group: patients aged 75 and more with cancer with oncogeriatric consultation

Other: Data collection

without oncogeriatric consultation

without oncogeriatric consultation" group: patients aged 75 and more with cancer without oncogeriatric consultation

Other: Data collection

Interventions

Description: quality of life assessment

with oncogeriatric consultationwithout oncogeriatric consultation

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients aged of 75 and more with cancer

You may qualify if:

  • male or female
  • aged of 75 and more
  • with cancer
  • with indication of oncogeriatric consultation according G8
  • agreeing to participate in the study

You may not qualify if:

  • less than 75 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Godinot

Reims, Grand Est, 51100, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2021

First Posted

December 20, 2021

Study Start

January 4, 2022

Primary Completion

June 1, 2022

Study Completion

August 1, 2022

Last Updated

March 25, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations